BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doumouras BS, Lee DS, Levy WC, Alba AC. An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best? Curr Heart Fail Rep 2018;15:24-36. [PMID: 29404976 DOI: 10.1007/s11897-018-0375-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Beyazal OF, Kervan Ü, Karahan M, Kocabeyoğlu SS, Sert DE, Temizhan A, Demirkan B, Akdi M, Konşuk Ünlü H, Çatav Z. Relationship Between Preoperative NT-proBNP and Postoperative Adverse Events in Patients with Left Ventricular Assist Device. Int J Artif Organs. [DOI: 10.1177/03913988221111406] [Reference Citation Analysis]
2 Dziewięcka E, Winiarczyk M, Wiśniowska-śmiałek S, Karabinowska-małocha A, Gliniak M, Robak J, Kaciczak M, Leszek P, Celińska-spodar M, Dziewięcki M, Rubiś P. Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy. JPM 2022;12:236. [DOI: 10.3390/jpm12020236] [Reference Citation Analysis]
3 Vazquez-Montes MDLA, Debray TPA, Taylor KS, Speich B, Jones N, Collins GS, Hobbs FDRR, Magriplis E, Maruri-Aguilar H, Moons KGM, Parissis J, Perera R, Roberts N, Taylor CJ, Kadoglou NPE, Trivella M; proBHF group. UMBRELLA protocol: systematic reviews of multivariable biomarker prognostic models developed to predict clinical outcomes in patients with heart failure. Diagn Progn Res 2020;4:13. [PMID: 32864468 DOI: 10.1186/s41512-020-00081-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lino DOC, Freitas IA, Meneses GC, Martins AMC, Daher EF, Rocha JHC, Silva Junior GB. Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure. Braz J Med Biol Res 2019;52:e8658. [PMID: 31778438 DOI: 10.1590/1414-431X20198658] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Ebong I, Mazimba S, Breathett K. Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making. Curr Heart Fail Rep 2019;16:274-84. [PMID: 31741231 DOI: 10.1007/s11897-019-00447-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Rodriguez M, Hernandez M, Cheungpasitporn W, Kashani KB, Riaz I, Rangaswami J, Herzog E, Guglin M, Krittanawong C. Hyponatremia in Heart Failure: Pathogenesis and Management. Curr Cardiol Rev 2019;15:252-61. [PMID: 30843491 DOI: 10.2174/1573403X15666190306111812] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
7 Adler ED, Voors AA, Klein L, Macheret F, Braun OO, Urey MA, Zhu W, Sama I, Tadel M, Campagnari C, Greenberg B, Yagil A. Improving risk prediction in heart failure using machine learning. Eur J Heart Fail 2020;22:139-47. [PMID: 31721391 DOI: 10.1002/ejhf.1628] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
8 Salzano A, Marra AM, D’assante R, Arcopinto M, Bossone E, Suzuki T, Cittadini A. Biomarkers and Imaging. Heart Failure Clinics 2019;15:321-31. [DOI: 10.1016/j.hfc.2018.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
9 O'Connor C, Fiuzat M, Mulder H, Coles A, Ahmad T, Ezekowitz JA, Adams KF, Piña IL, Anstrom KJ, Cooper LS, Mark DB, Whellan DJ, Januzzi JL Jr, Leifer ES, Felker GM. Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score. Eur J Heart Fail 2019;21:770-8. [PMID: 30919549 DOI: 10.1002/ejhf.1450] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]